Genedata and Roche Join Forces in Proteomics Process
Complete the form below to unlock access to ALL audio articles.
Genedata has announced an agreement with Roche for the company’s Genedata Expressionist ® Refiner MS module.
As integral part of the Genedata Expressionist platform for biomarker discovery, Refiner MS performs automated quality assessment and pre-processing of mass spectrometry based proteomics and metabolomics data.
The module handles all MS data formats in a flexible high throughput process, providing real-time interactive data quality assessment and processing hundreds of chromatograms simultaneously.
This high flexibility/high throughput duality accounts for the value Refiner MS adds to Roche`s biomarker discovery and diagnostic strategy.
Dr. Hanno Langen, Section Head Proteomics-Pathways-Functional Genomics in the Roche Molecular Medicine Laboratories in Basel, explains, “Thanks to its open architecture, Refiner MS can be easily positioned in our lab workflows, allowing for optimal integration. The high performance qualities make it a key element in our proteomics process, for which the processing of large datasets is fundamental.”
“We are proud to support Roche in further developing their biomarker discovery operations,” says Dr. Othmar Pfannes, CEO of Genedata AG. “The successful positioning of Refiner MS in such a complex, multifaceted environment validates its excellent suitability for modern proteomics applications.”
